Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Notice to Our Valued Users

Elsevier has made the difficult decision to close PracticeUpdate permanently. There will be no new content published, effective immediately. Although we are all disappointed by this news, we are incredibly grateful for your engagement and support over the years.

We thank the Editorial Boards, Advisory Boards, and Editorial Contributors for their many years of dedication to educating the healthcare community. Our appreciation extends to the many contributors who have shared their valuable time and expertise to help us parse the latest research over the years.

We encourage you to explore our other offerings such as ScienceDirect and ClinicalKey, which continue to provide valuable insights and information to help you excel in your practice.

If you have any questions or need assistance, please see the FAQs section or contact the support team. Thank you for being a part of the PracticeUpdate community!

featured

Published in Von Hippel-Lindau Disease and

Journal Scan / Research · October 25, 2022

The P81S Mutation in the von Hippel–Lindau Protein Alters Its Tumour Suppressor Function in ccRCC

British Journal of Cancer

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Sign in

Not a member?

Join for free

Additional Info

Article Citation

British Journal of Cancer

Mutation of the proline P81 into a serine modifies the tumour suppressor function of the von Hippel-Lindau gene in the ccRCC

Br. J. Cancer 2022 Sep 29;[EPub Ahead of Print], F Chesnel, E Jullion, O Delalande, A Couturier, A Alusse, X Le Goff, M Lenglet, B Gardie, C Abadie, Y Arlot-Bonnemains

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Notice to Our Valued Users

Renal Cell Carcinoma

The P81S Mutation in the von Hippel–Lindau Protein Alters Its Tumour Suppressor Function in ccRCC

Additional Info

Mutation of the proline P81 into a serine modifies the tumour suppressor function of the von Hippel-Lindau gene in the ccRCC

Further Reading

2024 Top Story in von Hippel-Lindau Disease: Belzutifan for Treatment of Pancreatic Neuroendocrine Tumors

Prevalence and Economic Burden of von Hippel–Lindau Disease–Associated CNS Hemangioblastomas and Pancreatic Neuroendocrine Tumors in the US

Prognostic Factors Associated With VHL-Related Pancreatic Neuroendocrine Tumors

Classification of 164 Challenging VHL Variants Based on Genotype–Phenotype Correlation

ASCO 2024: Abstract Recommendations From Dr. Amit Tirosh for von Hippel–Lindau Disease

Belzutifan for von Hippel–Lindau Disease–Associated Pancreatic Lesions

Inter- and Intra-Tumor Heterogeneity of Genetic and Immune Profiles in Inherited Renal Cell Carcinoma

Supratentorial Collision Tumor of Hemangioblastoma and Metastatic Clear Cell Renal Cell Carcinoma in a Patient With von Hippel–Lindau Disease

2023 Top Story in von Hippel–Lindau Disease: Guidelines for the Surveillance of Patients With von Hippel–Lindau Disease

68Ga-DOTANOC PET/CT for Screening for and Surveillance of von Hippel–Lindau Disease

Outcomes of and Indications for Renal Transplantation in Patients With von Hippel–Lindau Disease

Recently Updated